(Q33348283)

26 July 2017

1 reference

title

Pharmacotherapy of heparin- induced thrombocytopenia (English)

1 reference

26 July 2017

0 references

1 reference

William E Dager

1

1 reference

26 July 2017

Richard H White

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Expert Opinion on Pharmacotherapy

26 July 2017

published in

1 reference

26 July 2017

volume

4

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

919-940

1 reference

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Newer strategies for the treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Transient global amnesia associated with acute heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Kinetic mechanism for the interaction of Hirulog with thrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Hirudin in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Lepirudin dosing in dialysis-dependent renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Heparin-induced thrombocytopenia in coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.6.919

21 January 2018

Identifiers

DOI

10.1517/14656566.4.6.919

1 reference

26 July 2017

1 reference